A novel mutation in protein C gene (PROC) causing severe phenotype in neonatal period

2013 ◽  
Vol 61 (4) ◽  
pp. 763-764 ◽  
Author(s):  
Sule Unal ◽  
Fatma Gumruk ◽  
Sule Yigit ◽  
Murat Tuncer ◽  
Betul Tavil ◽  
...  
Author(s):  
Andreia Carvalho ◽  
Carmen Costa ◽  
Miguel Pinto ◽  
Ricardo Taipa ◽  
Ana Gonçalves ◽  
...  

AbstractX-linked myotubular myopathy (XLMTM), a centronuclear congenital myopathy secondary to pathogenic variants in the MTM1 gene encoding myotubularin, is typically recognized for its classic and severe phenotype which includes neonatal hypotonia, severe muscle weakness, long-term ventilator dependence, markedly delayed gross motor milestones with inability to independently ambulate, and a high neonatal and childhood mortality. However, milder congenital forms of the condition and other phenotypes are recognized. We describe a 6-year-old boy with a mild XLMTM phenotype with independent gait and no respiratory insufficiency even in the neonatal period. The child has a hemizygous novel splice site variant in the MTM1 gene (c.232–25A > T) whose pathogenicity was confirmed by cDNA studies (exon 5 skipping) and muscle biopsy findings. We also compared the phenotype of our patient with the few reported cases that presented a mild XLMTM phenotype and no respiratory distress at birth, and discussed the potential mechanisms underlying this phenotype such as the presence of residual expression of the normal myotubularin transcript.


2020 ◽  
Vol 95 (12) ◽  
pp. 1616-1621
Author(s):  
Kyle L. MacQuarrie ◽  
Olatundun Williams ◽  
Kenneth D. Friedman ◽  
Rachel S. Bercovitz

Medicine ◽  
2018 ◽  
Vol 97 (42) ◽  
pp. e12872 ◽  
Author(s):  
Myriam Ley-Martos ◽  
Juan M. Guerrero ◽  
Marta Lucas-Javato ◽  
Cristina Remón-García ◽  
J. Raúl García-Lozano ◽  
...  

2003 ◽  
Vol 123 (3) ◽  
pp. 496-501 ◽  
Author(s):  
A. D. Mumford ◽  
J. H. McVey ◽  
C. V. Morse ◽  
K. Gomez ◽  
M. Steen ◽  
...  

2007 ◽  
Vol 60 (3) ◽  
pp. 311-314
Author(s):  
Pablo García-Pavía ◽  
Javier Segovia ◽  
Jesús Molano ◽  
Roberto Mora ◽  
Frederic Kontny ◽  
...  

Neurogenetics ◽  
2009 ◽  
Vol 10 (4) ◽  
pp. 319-323 ◽  
Author(s):  
M. Traoré ◽  
G. Landouré ◽  
W. Motley ◽  
M. Sangaré ◽  
K. Meilleur ◽  
...  

1994 ◽  
Vol 72 (02) ◽  
pp. 203-208 ◽  
Author(s):  
R G Doig ◽  
C G Begley ◽  
K M McGrath

SummaryThis report describes five families with symptomatic hereditary protein C deficiency. Using a polymerase chain reaction (PCR)-based method, the entire coding sequence and intron-exon boundaries of the protein C gene was amplified from genomic DNA. In each family a single point mutation in the protein C gene was identified. Two unrelated families were found to share the same mutation, while the other three had different mutations. In the first two families with type I protein C deficiency the normal cytosine residue at nucleotide position 8551 in the protein C gene was replaced by thymidine leading to substitution of the normal proline residue at amino acid position 279 by leucine. In the third family with type I deficiency a previously undescribed mutation was identified. In this family the guanosine residue at position 8559 was replaced by adenosine (glycine 282 substituted by serine). In the fourth family, also with type I deficiency, guanosine 8589 was replaced by adenosine (glycine 292 substituted by serine). The fifth family had type II deficiency and in affected members cytosine 8769 was replaced by thymidine (arginine 352 substituted by tryptophan). All these mutations lead to amino acid substitutions in the serine protease domain of the mature protein. All were able to be confirmed by restriction enzyme analysis of PCR-derived DNA. In addition the novel mutation at nucleotide position 8559 was also demonstrable using single strand conformation polymorphism (SSCP) analysis of PCR-derived DNA. These mutations were likely examples of deamination of methylated cytosine occurring in cytosine-phosphate-guanosine (CpG) dinucleotide sequences. These findings confirm the genetic heterogeneity of hereditary protein C deficiency in these families.


2000 ◽  
Vol 84 (09) ◽  
pp. 424-428 ◽  
Author(s):  
Kristiina Kuismanen ◽  
Päivi Holopainen ◽  
Elina Vahtera ◽  
Vesa Rasi ◽  
Tom Krusius ◽  
...  

SummaryThe present study investigated the genetic basis for type II protein C deficiency in Finland, where this form has an unusually high incidence. We demonstrated that, first, a single novel mutation W380G in the protein C gene (PROC) explained 25/26 index patients, estimated to represent two thirds of all families with type II deficiency in Finland. Second, extended chromosomal conservation, i. e. a specific haplotype, around the W380G mutation was indicated in unrelated patients. Third, a local geographical origin for the W380G mutation was suggested by genealogical data. These results are in contrast to the heterogeneity in type II protein C deficiency elsewhere, but closely parallel disorders of the Finnish disease heritage. The high frequency of the type II disease can be explained by founder effect and subsequent enrichment of a single mutation in Finland. The present study also provided a simple means for genetic diagnosis of this disease and the genetic test can be included in the routine screenings in this population.


Sign in / Sign up

Export Citation Format

Share Document